Clinical Lung Cancer

1

Mesothelin Levels in Urine are Affected by Glomerular Leakage and Tubular Reabsorption

Kevin Hollevoet, Marijn M. Speeckaert, An-Sofie Decavele, Raymond Vanholder, Jan P. van Meerbeeck, Joris R. Delanghe

Journal:

Year:

2012

Language:

english

File:

PDF, 380 KB

english, 2012

2

A Multicenter Phase II Study of Adjuvant Chemotherapy With Oral Fluoropyrimidine S-1 for Non–Small-Cell Lung Cancer: High Completion and Survival Rates

Tomoshi Tsuchiya, Takeshi Nagayasu, Naoya Yamasaki, Keitaro Matsumoto, Takuro Miyazaki, Tsutomu Tagawa, Akihiro Nakamura, Hiroyuki Minami, Hideki Taniguchi, Shinji Akamine, Hiroshi Hisano, Yoshitaka T

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 297 KB

english, 2012

3

Prospective Study of Gefitinib Readministration After Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer Who Previously Responded to Gefitinib

Tomonobu Koizumi, Toshihiko Agatsuma, Kayoko Ikegami, Toshiro Suzuki, Takashi Kobayashi, Shintaro Kanda, Sumiko Yoshikawa, Keishi Kubo, Takayuki Shiina, Keiichirou Takasuna, Akemi Matsuo, Muneharu Hay

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 322 KB

english, 2012

4

hTERT Gene Amplification and Clinical Significance in Pleural Effusions of Patients With Lung Cancer

Na Cha, Xiao-Yan Li, Yu-Jie Zhao, En-Hua Wang, Guang-Ping Wu

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 423 KB

english, 2012

5

Diffuse Reflectance Spectroscopy: A New Guidance Tool for Improvement of Biopsy Procedures in Lung Malignancies

Daniel J. Evers, Rami Nachabé, Houke M. Klomp, Johanna W. van Sandick, Michel W. Wouters, Gerald W. Lucassen, Benno H.W. Hendriks, Jelle Wesseling, Theo J.M. Ruers

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 1.27 MB

english, 2012

6

Knockdown of the Epidermal Growth Factor Receptor Gene to Investigate Its Therapeutic Potential for the Treatment of Non–Small-Cell Lung Cancers

Kazuhiko Shien, Tsuyoshi Ueno, Kazunori Tsukuda, Junichi Soh, Kenichi Suda, Takafumi Kubo, Masashi Furukawa, Takayuki Muraoka, Yuho Maki, Norimitsu Tanaka, Hiromasa Yamamoto, Katsuyuki Kiura, Tetsuya

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 950 KB

english, 2012

7

A Diagnostic Program for Patients Suspected of Having Lung Cancer

Jos A. Stigt, Steven M. Uil, Ad H. Oostdijk, James E. Boers, Jan-Willem K. van den Berg, Harry J.M. Groen

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 547 KB

english, 2012

8

Socioeconomic Disparities in Lung Cancer Treatment and Outcomes Persist Within a Single Academic Medical Center

Jeffrey T. Yorio, Jingsheng Yan, Yang Xie, David E. Gerber

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 613 KB

english, 2012

9

A Phase Ib, Dose-Finding Study of Erlotinib in Combination With a Fixed Dose of Pertuzumab in Patients With Advanced Non–Small-Cell Lung Cancer

Enriqueta Felip, Malcolm Ranson, Susana Cedrés, Emma Dean, Mike Brewster, Pablo Martínez, Virginia McNally, Graham Ross, Danny Galdermans

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 499 KB

english, 2012

10

Novel High-Sensitive D-Dimer Determination Predicts Chemotherapy-Associated Venous Thromboembolism in Intermediate Risk Lung Cancer Patients

Patrizia Ferroni, Francesca Martini, Ilaria Portarena, Gioia Massimiani, Silvia Riondino, Francesca La Farina, Sabrina Mariotti, Fiorella Guadagni, Mario Roselli

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 335 KB

english, 2012

11

Role of Hormone Receptor Expression in Patients With Advanced-Stage Lung Cancer Treated With Chemotherapy

Valentina Monica, Marina Longo, Barbara Felice, Giorgio V. Scagliotti, Mauro Papotti, Silvia Novello

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 481 KB

english, 2012

12

Chemotherapy is Beneficial for Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Patients Aged 70-74, 75-79, and 80 or Older in Japan

Tomoya Kawaguchi, Akihiro Tamiya, Atsuhisa Tamura, Masamichi Arao, Ryusei Saito, Akihide Matsumura, Sai-Hong I. Ou, Taro Tamura

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 444 KB

english, 2012

13

The Role of Endobronchial Ultrasound in Lung Cancer Diagnosis and Staging: A Comprehensive Review

Ioannis Kokkonouzis, Alexios S. Strimpakos, Ioannis Lampaditis, Sotirios Tsimpoukis, Kostas N. Syrigos

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 1.05 MB

english, 2012

14

Primary Pleuropulmonary Sarcoma: A Rare Disease Entity

Matteo Giaj Levra, Silvia Novello, Giorgio V. Scagliotti, Mauro Papotti, Axel Le Cesne

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 4.88 MB

english, 2012

15

Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non–Small-Cell Lung Cancer

David R. Spigel, Martin J. Edelman, Tony Mok, Kenneth O'Byrne, Luis Paz-Ares, Wei Yu, Karen Rittweger, Holger Thurm

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 255 KB

english, 2012

16

A Randomized, Double-Blind, Phase III Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non–Small-Cell Lung Cancer After Disease Progression After 1 Previous Platinum-Based Therapy (REVEL): Treatment Rationale and Study Design

Edward B. Garon, Dachuang Cao, Ekaterine Alexandris, William J. John, Sergey Yurasov, Maurice Perol

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 264 KB

english, 2012

17

Editorial Board

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

18

Volume 13; Issue 6

Mesothelin Levels in Urine are Affected by Glomerular Leakage and Tubular Reabsorption

A Multicenter Phase II Study of Adjuvant Chemotherapy With Oral Fluoropyrimidine S-1 for Non–Small-Cell Lung Cancer: High Completion and Survival Rates

Prospective Study of Gefitinib Readministration After Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer Who Previously Responded to Gefitinib

hTERT Gene Amplification and Clinical Significance in Pleural Effusions of Patients With Lung Cancer

Diffuse Reflectance Spectroscopy: A New Guidance Tool for Improvement of Biopsy Procedures in Lung Malignancies

Knockdown of the Epidermal Growth Factor Receptor Gene to Investigate Its Therapeutic Potential for the Treatment of Non–Small-Cell Lung Cancers

A Diagnostic Program for Patients Suspected of Having Lung Cancer

Socioeconomic Disparities in Lung Cancer Treatment and Outcomes Persist Within a Single Academic Medical Center

A Phase Ib, Dose-Finding Study of Erlotinib in Combination With a Fixed Dose of Pertuzumab in Patients With Advanced Non–Small-Cell Lung Cancer

Novel High-Sensitive D-Dimer Determination Predicts Chemotherapy-Associated Venous Thromboembolism in Intermediate Risk Lung Cancer Patients

Role of Hormone Receptor Expression in Patients With Advanced-Stage Lung Cancer Treated With Chemotherapy

Chemotherapy is Beneficial for Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Patients Aged 70-74, 75-79, and 80 or Older in Japan

The Role of Endobronchial Ultrasound in Lung Cancer Diagnosis and Staging: A Comprehensive Review

Primary Pleuropulmonary Sarcoma: A Rare Disease Entity

Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non–Small-Cell Lung Cancer

A Randomized, Double-Blind, Phase III Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non–Small-Cell Lung Cancer After Disease Progression After 1 Previous Platinum-Based Therapy (REVEL): Treatment Rationale and Study Design

Editorial Board

Table of Contents